We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.95%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
+$950M
(+7.4%)
Cap. Flow
+$723M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
11.77%
Holding
2,830
New
300
Increased
700
Reduced
765
Closed
275
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corning
GLW
|
+$45.6M |
| 2 |
Accenture
ACN
|
+$41.1M |
| 3 |
OA
Orbital ATK, Inc.
OA
|
+$33.7M |
| 4 |
Hormel Foods
HRL
|
+$32.9M |
| 5 |
PACCAR
PCAR
|
+$32.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$61.7M |
| 2 |
RFMD
RF MICRO DEVICES INC
RFMD
|
+$23.5M |
| 3 |
ORB
ORBITAL SCIENCES CORP
ORB
|
+$21.2M |
| 4 |
TAL
TAL INTERNATIONAL GROUP, INC.
TAL
|
+$21.1M |
| 5 |
Hope Bancorp
HOPE
|
+$19.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.82% |
| 2 | Healthcare | 14.78% |
| 3 | Industrials | 11.92% |
| 4 | Financials | 9.77% |
| 5 | Consumer Discretionary | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMA
476
DELISTED
Comerica
CMA
| $3.37M | 0.02% |
74,598
-176,466
| -70% | -$7.87M |
|
477
Capital One
COF
$127B
| $3.36M | 0.02% |
42,697
-76,222
| -64% | -$5.99M |
|
478
American International
AIG
$42B
| $3.35M | 0.02% |
61,213
-2,033
| -3% | -$109K |
|
479
iShares Russell 2000 Value ETF
IWN
$14.4B
| $3.34M | 0.02% |
32,408
| – | – |
|
|
SE
480
DELISTED
Spectra Energy Corp Wi
SE
| $3.32M | 0.02% |
91,928
+1,384
| +2% | +$48.4K |
|
481
Cedar Fair
FUN
$1.8B
| $3.32M | 0.02% |
57,901
-59
| -0.1% | -$3.19K |
|
482
Oneok
OKE
$56.4B
| $3.32M | 0.02% |
68,866
-100,377
| -59% | -$4.59M |
|
483
Zimmer Biomet
ZBH
$17.8B
| $3.3M | 0.02% |
28,905
+106
| +0.4% | +$12.1K |
|
|
DHC
484
Diversified Healthcare Trust
DHC
$2.28B
| $3.27M | 0.02% |
+148,643
| New | +$3.32M |
|
485
Ingredion
INGR
$6.4B
| $3.27M | 0.02% |
42,000
+359
| +0.9% | +$29.4K |
|
486
Jabil
JBL
$32.6B
| $3.26M | 0.02% |
139,624
+124,637
| +832% | +$2.72M |
|
487
Federal Signal
FSS
$7.22B
| $3.26M | 0.02% |
206,470
+39,050
| +23% | +$608K |
|
488
Expeditors International
EXPD
$22.4B
| $3.25M | 0.02% |
67,443
+23,013
| +52% | +$1.06M |
|
|
SPN
489
DELISTED
Superior Energy Services, Inc.
SPN
| $3.25M | 0.02% |
14,546
+3,410
| +31% | +$708K |
|
490
Snap-on
SNA
$21.1B
| $3.25M | 0.02% |
22,090
-435
| -2% | -$61.2K |
|
491
State Street
STT
$50.7B
| $3.21M | 0.02% |
43,617
+195
| +0.4% | +$14.6K |
|
492
Jones Lang LaSalle
JLL
$15.5B
| $3.19M | 0.02% |
18,749
+473
| +3% | +$74.6K |
|
493
Welltower
WELL
$175B
| $3.19M | 0.02% |
41,255
-547
| -1% | -$43.1K |
|
494
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $3.15M | 0.02% |
103,775
-10,830
| -9% | -$320K |
|
495
AB InBev
BUD
$156B
| $3.13M | 0.02% |
25,701
-110
| -0.4% | -$13.3K |
|
496
TotalEnergies
TTE
$187B
| $3.1M | 0.02% |
62,447
+8,760
| +16% | +$449K |
|
|
SCLN
497
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $3.1M | 0.02% |
349,390
+123,110
| +54% | +$981K |
|
498
Vertex Pharmaceuticals
VRTX
$122B
| $3.09M | 0.02% |
26,174
| – | – |
|
|
AHGP
499
DELISTED
Alliance Holdings GP
AHGP
| $3.06M | 0.02% |
59,295
+4,635
| +8% | +$252K |
|
500
Genesis Energy
GEL
$1.81B
| $3.06M | 0.02% |
65,161
-550
| -0.8% | -$24.4K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2015 Portfolio in Review
As of Q1 2015, Glenmede Trust held 2,830 positions worth $13.7B, up 7.4% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Glenmede Trust deployed $723M of net new capital in Q1 2015, opening 300 new positions and adding to 700 existing holdings. Its largest new stake was Qorvo: 411,283 shares worth $32.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was NOV, an estimated $18.7M trimmed.
- Glenmede Trust's largest Q1 2015 buy was Qorvo: 411,283 shares worth $32.8M.
- Glenmede Trust added most to Corning in Q1 2015, an estimated $45.6M increase.
- Glenmede Trust's biggest Q1 2015 reduction was NOV, cutting an estimated $18.7M.
- Glenmede Trust fully exited Allergan Inc in Q1 2015, selling an estimated $61.7M.
- Glenmede Trust's ten largest holdings make up 12% of its $13.7B portfolio in Q1 2015.
- Glenmede Trust opened 300 new positions and closed 275 in Q1 2015.
- Glenmede Trust's portfolio value rose 7.4% quarter-over-quarter to $13.7B.
Based on Glenmede Trust's 13F filing for Q1 2015, filed 29 Apr 2015.